Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients.

ABSTRACT:

SUBMITTER: Ocio EM 

PROVIDER: S-EPMC9894356 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature